Cluster versus conventional immunotherapy in patients allergic to Dermatophagoides pteronyssinus: A controlled study of in vivo and in vitro parameters

Journal of Investigational Allergology and Clinical Immunology

Volumn 9, Issue 3, 1999, Pages 146-154

  Muro, M D ^a   Tabar, A I ^a,c   Lizaso, M T ^a   Quirce, S ^a   Polo, F ^b   Garcia B E ^a  

^a Universidad Pública de Navarra   (Spain)

^b Celltech Pharma   (Spain)

^c Seccion de Alergologia   (Spain)

Author keywords

Cluster schedule; Conjunctival provocation test; Dermatophagoides pteronyssinus; Immunotherapy; In vitro parameters; Skin prick test

Indexed keywords

HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G4;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATOPHAGOIDES PTERONYSSINUS; DRUG EFFICACY; DRUG SAFETY; FEMALE; HOUSE DUST ALLERGY; HUMAN; IMMUNOTHERAPY; INTRADERMAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRICK TEST; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; ASTHMA; CHILD; CHILD, PRESCHOOL; CONJUNCTIVA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOTHERAPY; MALE; MIDDLE AGED; MITES; RESPIRATORY HYPERSENSITIVITY; RHINITIS; SKIN TESTS;

EID: 0032777702     PISSN: 10189068     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Tabar, A.I., Muro, M.D., García, B.E., Álvarez, M.J., Acero, S., Rico, P., Olaguíbel, J.M. Dermatophagoides pteronyssinus cluster immunotherapy. A controlled trial of safety and clinical efficacy. J Invest Allergol Clin Immunol 1999, 9 (3): 155-64.
2. Hedlin, G., Silber, G., Naclerio, R.M. Attenuation of allergen sensitivity early in the course of ragweed immunotherapy. J Allergy Clin Immunol 1989, 84: 390-9.
3. Creticos, P.S., Adkinson, N.F., Kagey-Sobotka, A. Nasal challenge with ragweed pollen in hay fever patients: Effect of immunotherapy. J Clin Invest 1985, 76: 2247-54.
4. Bousquet, J., Michel, F.B. Specific immunotherapy. Allergy 1988, 43 (Suppl. 8): 16-22.
5. Durham, S.R., Varney, V., Gaga, M., Frew, A.J., Jacobson, M., Kay, A.B. Immunotherapy and allergic inflammation. Clin Exp Allergy 1991, 21 (Suppl. 1): 206-10.
6. Lichtenstein, L.M., Valentine, M.D., Norman, P.S. A reevaluation of immunotherapy for asthma. Am Rev Respir Dis 1984, 129: 657-9.
7. Brighton, W.D., Topping, M.D., Henocq, E. Activity units for allergen extracts. Clin Allergy 1979, 9: 591-6.
8. Lombardero, M., González, R., Duffort, O., Juan, F., Ayuso, R., Ventas, P., Cortés, C., Carreira, J. Evaluación de la actividad biológica total y composición alergénica de extractos alergénicos. Allergol Immunopathol (Madrid) 1986, 14: 189-95.
9. Ventas, P., Lombardero, M., Duffort, O. Cuantificación de los alergenos Der p 1 y Der f 1 de los ácaros y Fel d 1 de gato mediante un ELISA en fase sólida. Rev Esp Alergol Inmunol Clin 1990, 5: 71-5.
10. Skin test subcommittee EAACI. Skin test used in type I allergy testing. Allergy 1989, 44 (Suppl. 10): 22-30.
11. Pipkorn, U. Pharmacological influence of antiallergic medication on in vivo allergen testing. Allergy 1988, 43: 81-6.
12. Martín, S., Cuesta, P., Rico, P., Cortés, C. A program to analyze cutaneous responses by means of parallel line assay (abstr.). Allergy 1992, 47: 129.
13. Finney, D.J. Statistical Methods in Biological Assays, 3rd ed. Charles Griffin & Co Ltd.: London 1978, 69-104.
14. Möller, C.H., Björksten, B., Nilsson, G., Dreborg, S. The precision of the conjunctival provocation test. Allergy 1984, 39: 37-41.
15. Dreborg, S. Conjunctival provocation test (CPT). Postgraduate course in Uppsala 1985. Allergy 1985, 40 (Suppl. 4): IIIB:6.
16. Sánchez-Madrid, F., Morago, G., Corbi, A.L., Carreira, J. Monoclonal antibodies to three distinct epitopes on human IgE: Their use for determination of allergen-specific IgE. J Immunol Methods 1984, 73: 367-78.
17. Jimeno, L., Carreira, J., Lombardero, M. Obtention of monoclonal antibodies against human IgG4 using two different immunization strategies: Development of a biotin-based ELISA for IgG4 quantitation. Int Arch Allergy Appl Immunol 1990, 92: 175-82.
18. Moscoso, J., Jimeno, L., Obispo, T., Carreira, J. Monoclonal antibodies against human IgE. Identification of an epitope sharing properties with the high affinity receptor binding site. Mol Immunol 1991, 55: 134-46.
19. Morago, G., Carreira, J., Corbi, A.L., Sánchez-Madrid, F. Preparación de anticuerpos monoclonales frente a IgG e IgE humanas y su utilización como reactivos en el diagnóstico de enfermedades alérgicas. Inmunologia 1985, 4: 111-8.
20. SEAIC and ALK-Abelló SA. Alergológica. Factores Epidemiológicos, Clínicos y Socioeconómicos de las Enfermedades Alérgicas en España. NILO Industrias Gráficas: Madrid 1995, 237-56.
21. Tabar, A.I., García, B.E., Rodríguez, A., Olaguíbel, J.M., Muro, M.D., Quirce, S. A prospective safety-monitoring study of immunotherapy with biologically standardized extracts. Allergy 1993, 48: 450-3.
22. Olaguíbel, J.M., Tabar, A.I., García, B.E., Cortés, C. Immunotherapy with standardized extract of Dermatophagoides pteronyssinus in bronchial asthma: A dose-titration study. Allergy 1997, 52: 168-78.
23. Dreborg, S., Mosbech, H., Weeke, B. Immunotherapy and bronchial asthma. In: Clinical Immunology and Allergy. The Allergic Basis of Asthma. Kay, A.B. (Ed.). Baillière Tindall: London 1988, 245-58.
24. Bousquet, J., Maasch, H., Martinot, B., Hejjaoui, A., Wahl, R., Michel, F.B. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy. J Allergy Clin Immunol 1988, 82: 439-46.
25. Mosbech, H., Dreborg, S., Frolund, L., Ljungstedt-Pahlman, I., Svendsen, U.G. Hyposensitization in asthmatics with mPEG modified and unmodified house dust mite extracts. I. Clinical effect evaluated by diary cards and a retrospective assessment. Allergy 1989, 44: 487-98.
26. Walker, S.M., Varney, V.A., Gaga, M., Jacobson, M.R., Durham, S.R. Grass pollen immunotherapy: Efficacy and safety during a 4-year follow-up study. Allergy 1995, 50: 405-13.
27. Urbanek, R., Khun, W., Holgersson, M., Dreborg, S. Changes in conjunctival provocation test and skin prick test, specific IgE and IgG during immunotherapy with grass pollen preparations. Ann Allergy 1985, 55: 259-64.
28. Dreborg, S., Agrell, B., Foucard, T., Kjellman, N., Koivikko, A., Nilsson, S. A double-blind, multicenter immunotherapy trial in children, using a purified and standardized Cladosporium herbarum preparation. I. Clinical results. Allergy 1986, 41: 131-40.
29. Osterballe, O., Wenstein, H., Norn, S., Prahl, P.L., Skov, P., Weeke, B. Immunotherapy with grass pollen major allergens. Immunological results from a prospective 3-year double blind study. Allergy 1982, 37: 491-501.
30. Müller, U., Lanner, A., Schmid, P., Bischof, M., Dreborg, S., Hoigne, R. A double blind study on immunotherapy with chemically modified honey bee venom: Monomethoxy polyethylene glycol-coupled versus crude honey bee venom. Int Arch Allergy Appl Immun 1985, 77: 201-3.
31. Djurup, R., Malling, H.J., Sondergaard, I.B., Weeke, B. The IgE and IgG subclass antibody response in patients allergic to yellow jacket venom undergoing different regimens of venom immunotherapy. J Allergy Clin Immunol 1985, 76: 46-55.
32. Mosbech, H., Malling, H.J., Biering, I., Bowadt, H., Soborg, M., Weeke, B., Lowenstein, H. Immunotherapy with yellow jacket venom. A comparative study including three different extracts, one adsorbed to aluminium hydroxide and two unmodified. Allergy 1986, 41 (2): 95-103.
33. Muñoz, D., Bernaola, G., Audicana, M., Fernández, E., Fernández, L. Inmunoterapia rápida en pacientes polínicos. Evolución clínica y variación de parámetros in vivo e in vitro. Rev Esp Alergol Inmunol Clín 1991, 6 (Suppl. 1): 57-61.
34. Golden, D.B.K., Meyers, D.A., Kagey-Sobotka, A., Valentine, M.D., Lichtenstein, L.M. Clinical relevance of the venom specific IgG antibody level during immunotherapy. J Allergy Clin Immunol 1982, 69: 489-94.
35. Djurup, R., Osterballe, O. IgG subclass antibody response in grass pollen-allergic patients undergoing specific immunotherapy. Allergy 1984, 39: 433-41.
36. García, B.E., Sanz, M.L., Gato, J.J., Fernández, J., Oehling, A. IgG4 blocking effect on the release of antigen-specific histamine. J Invest Allergol Clin Immunol 1993, 3: 26-33.
37. Nakagawa, T., De Weck, A.L. Membrane receptors for the IgG4 subclass on human basophils and mast cells. Clin Rev Allergy 1983, 2: 197-206.